Solutions for Today, Future-Proofed for Tomorrow
The second-generation platform can independently operate complex inferencing and learning on extremely low-power AI devices delivering highly accurate, intelligent, responsive, real-time applications with greater reliability and security.
Akida now supports more complex algorithms and models, including high-resolution video object detection, segmentation and advanced time-series data applications, sequence prediction, and advanced speech recognition in low-power edge devices. This architecture also supports all convolutional, deep learning, and vision transformer networks and includes native support for spiking neural nets (SNN) with even greater efficiency and performance.
Akida 2nd Generation Platform Brief
The 2nd generation Akida builds on the existing technology foundation and supercharges the processing of raw time-continuous streaming data, such as video analytics, target tracking, audio classification, analysis of health monitoring data such as heart rate and respiratory rate for vital signs prediction, and time series analytics used in forecasting, and predictive production line maintenance. These capabilities are critically needed in industrial, automotive, digital health, smart home, and smart city applications.
... and some want to sell their BRN's for 36c with the 2nd generation AKIDA due this quarter? Just look what it can do! What a game changer this will be for BRN. The explosive revenue Sean speaks of near.
Not financial advice ... my opinion only.
- Forums
- ASX - By Stock
- BRN
- 2023 BrainChip Discussion
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

2023 BrainChip Discussion, page-3348
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online